Loading...

Bristol-Myers Squibb Company

BMY•NYSE
Healthcare
Drug Manufacturers - General
$58.71
$-0.31(-0.53%)
U.S. Market opens in 20h 9m

Bristol-Myers Squibb Company (BMY) Stock Overview

Explore Bristol-Myers Squibb Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap119.9B
P/E Ratio17.00
EPS (TTM)$3.46
ROE0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$58.69
3 Months$42.30
1 Year Target$50.55

BMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bristol-Myers Squibb Company (BMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $50.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.00 and a market capitalization of 119.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.53%
5-Day Change
-0.83%
1-Month Change
2.30%
3-Month Change
7.43%
6-Month Change
33.95%
Year-to-Date (YTD) Change
8.84%
1-Year Change
20.58%
3-Year Change
-16.77%
5-Year Change
-10.90%
All-Time (Max) Change
2792.12%

Contact Information

https://www.bms.com
609 252 4621
Route 206 & Province Line Road, Princeton, NJ, 08543

Company Facts

34,100 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions